Cargando…
Myopericarditis with hemorrhagic pericardial effusion following BNT162b2 mRNA COVID-19 vaccine()
Since the onset of the COVID-19 pandemic, to date, around 385 million cases have been diagnosed worldwide leading to an estimated 5.7 million death toll. Mass vaccination campaigns have been conducted to control the spread of infection with the most commonly used vaccines being Pfizer-BioNTech and M...
Autores principales: | Generette, Gabriela S., Troyer, James, Hemenway, Alice, Al Zoubi, Moamen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122740/ https://www.ncbi.nlm.nih.gov/pubmed/35646594 http://dx.doi.org/10.1016/j.idcr.2022.e01511 |
Ejemplares similares
-
Myopericarditis After BNT162b2 mRNA Vaccination With Incidental Intramyocardial Bridging
por: Elghazal, Mohamed, et al.
Publicado: (2023) -
BNT162B2 MRNA BOOSTER VACCINE-RELATED PERICARDITIS: A CASE COMPLICATED BY PERICARDIAL AND PLEURAL EFFUSIONS
por: WHITE, ANESHA, et al.
Publicado: (2022) -
Myopericarditis and Pericardial Effusion as the Initial Presentation of Systemic Lupus Erythematosus
por: Bezwada, Prema, et al.
Publicado: (2017) -
A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male
por: Kim, Dongwon, et al.
Publicado: (2021) -
COVID-19 Myopericarditis With Pericardial Effusion Complicated With Cardiac Tamponade and Rhabdomyolysis
por: Abdelmottaleb, Wael, et al.
Publicado: (2022)